News
Biotechnology company Moderna (NASDAQ:MRNA) announced better-than-expected revenue in Q2 CY2025, but sales fell by 41.1% year ...
Perhaps the most critical aspect of Moderna's business to pay attention to right now is its late-stage pipeline. The company ...
Barchart on MSN6d
Moderna Is Cutting 10,000 Jobs as Its Business Erodes. How Should You Play MRNA Stock Here?
Moderna (MRNA) skyrocketed to fame during the pandemic, delivering one of the first mRNA-based Covid-19 vaccines and quickly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback